Design Cloud

  • Home

  • About Us

    Company Profile HIstory Culture Honor
    • Company Profile

    • HIstory

    • Culture

    • Honor

  • Products

    Cardiovascular series Psychiatry series Hepatobiliary, Gastroenterology Series Respiratory series Anti-infective virus series Other series Large Infusion Series Huabao Tong Series Active Pharmaceutical Ingredient Series
    • Cardiovascular series

    • Psychiatry series

    • Hepatobiliary, Gastroenterology Series

    • Respiratory series

    • Anti-infective virus series

    • Other series

    • Large Infusion Series

    • Huabao Tong Series

    • Active Pharmaceutical Ingredient Series

  • R&D

    Academician Expert Workstation Medical Research and Industry Alliance
    • Academician Expert Workstation

    • Medical Research and Industry Alliance

  • News

    General News Party group dynamics Employee activity
    • General News

    • Party group dynamics

    • Employee activity

  • HR

    Talent Strategy Company recruitment
    • Talent Strategy

    • Company recruitment

  • Contact us

  • 中文版

Image Name

News

  • Home page

General News

Party group dynamics

Employee activity

2020

Date:

29 Aug,2022


1 Month, Renamed as Wanbangde Pharmaceutical Group Co., Ltd.

2 Month, Wanbangde Successfully Completes Restructuring and Goes Public (Stock Code 002082 ), the pharmaceutical group enters the publicly listed company system

Previous page

2021

2019

Next page

Related Recommendations

Image Name

2024/12/30

News | The Annual Meeting of Wanbande Pharmaceutical Group's Academician and Expert Workstation Successfully Held

Image Name

2024/12/30

For three consecutive years, Wanbande Pharmaceutical Group has been recognized among the Top 500 High-Tech Enterprises in Zhejiang Province for Innovation Capability!

Image Name

2024/12/30

Wanbangde achieves another breakthrough in innovative drug development—WP103 holds the potential to address the critical clinical need for treating neonatal HIE! This globally rare FDA dual-designated drug has once again received IND application acceptance.

< 1...345...78 > proceed page
  • Home

  • About Us

    • Company Profile

    • HIstory

    • Culture

    • Honor

  • Products

    • Cardiovascular series

    • Psychiatry series

    • Hepatobiliary, Gastroenterology Series

    • Respiratory series

    • Anti-infective virus series

    • Other series

    • Large Infusion Series

    • Huabao Tong Series

    • Active Pharmaceutical Ingredient Series

  • R&D

    • Academician Expert Workstation

    • Medical Research and Industry Alliance

  • News

    • General News

    • Party group dynamics

    • Employee activity

  • HR

    • Talent Strategy

    • Company recruitment

  • Contact us

  • 中文版

Image Name

Website Development: China Enterprise DynamicsTaizhou

Business license
浙ICP备10002622号-38